Form 4: UHS Director Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report


Universal Health Services Director Elliot J. Sussman exercised stock options and subsequently sold a portion of the acquired shares for tax withholding and personal reasons.

Summary

  • Elliot J. Sussman, a Director at Universal Health Services Inc. (UHS), engaged in multiple transactions involving Class B Common Stock.
  • On March 11, 2026, Sussman exercised options to acquire 1,250 shares of Class B Common Stock at an exercise price of $138.8 per share.
  • Concurrently, on March 11, 2026, he disposed of 932 shares at $186.28 for tax withholding purposes and sold an additional 318 shares at a weighted average price of $186.3455.
  • Following these transactions on March 11, 2026, Sussman directly owned 6,113 shares of Class B Common Stock.
  • On March 13, 2026, Sussman again exercised options to acquire 1,250 shares of Class B Common Stock at an exercise price of $138.8 per share.
  • On the same day, March 13, 2026, he disposed of 894 shares at $194.27 for tax withholding and sold another 356 shares at a weighted average price of $193.3742.
  • After all reported transactions, Sussman's direct beneficial ownership of Class B Common Stock remained at 6,113 shares.
  • The options exercised on both dates had vested ratably on March 17, 2022, March 17, 2023, March 17, 2024, and March 17, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It's a routine insider transaction involving option exercise and subsequent share sales for tax and personal reasons, with no net change in the director's direct beneficial ownership.

Positives

  • The director exercised options, indicating a prior belief in the company's value and the options being in-the-money.
  • The sale prices ($186.28, $186.3455, $194.27, $193.3742) are significantly higher than the exercise price of $138.8, suggesting a profitable transaction for the director.

Negatives

  • A portion of the shares acquired through option exercise was sold, which could be interpreted as the director monetizing compensation rather than increasing direct equity exposure.
  • The net effect of the transactions was no change in the director's direct beneficial ownership of Class B Common Stock, as shares acquired were offset by sales.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly option exercises followed by sales, are common events in the healthcare industry as executives monetize long-term incentive compensation. These transactions typically reflect personal financial planning rather than a direct signal about the company's immediate operational performance or strategic direction.

Comparison to Industry Standards

  • Insider option exercises and subsequent sales for tax purposes are standard practice across all industries, including healthcare.
  • The transaction prices reflect the market value of UHS stock at the time of sale, which can be compared to the performance of peers like HCA Healthcare (HCA) or Tenet Healthcare (THC) during the same period to gauge relative stock strength, though this filing itself does not provide such comparative data.

Stakeholder Impact

  • Shareholders: The transactions are routine and do not indicate a significant change in the director's confidence or the company's fundamentals. The sale of shares could slightly increase the float but is unlikely to have a material impact on the stock price given the volume relative to total shares outstanding.
  • Employees: No direct impact on employees is indicated.

Key Dates

DateDescription
03/17/2022First vesting date for the exercised stock options.
03/17/2023Second vesting date for the exercised stock options.
03/17/2024Third vesting date for the exercised stock options.
03/17/2025Fourth and final vesting date for the exercised stock options.
03/11/2026Date of option exercise and subsequent sale of Class B Common Stock.
03/13/2026Date of option exercise and subsequent sale of Class B Common Stock.
03/16/2026Expiration date for the derivative securities (options) mentioned in the filing.

Recommendation

hold

This Form 4 filing details routine insider transactions involving the exercise of vested stock options and subsequent sales for tax withholding and personal liquidity. The director's overall direct beneficial ownership of Class B Common Stock remained constant after these transactions. Such events are common and generally do not signal a change in the company's fundamental outlook or warrant a change in investment thesis. Therefore, a "hold" recommendation is appropriate as this filing provides no new information to alter an existing investment position.

Keywords

Universal Health Services, UHS, Elliot J. Sussman, Insider Trading, Form 4, Stock Options, Share Sale, Director Transactions, Healthcare Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.